Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M Année : 2021 Journal : Breast Cancer Res Treat
Sarcoidosis Versus Lymphoma?
Auteurs : Dal Lago L, Sarrand J, Woff E, Awada A, Vouche M, Pepersack T Année : 2021 Journal : Eur J Case Rep Intern Med
Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.
Auteurs : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T Année : 2021 Journal : Eur J Case Rep Intern Med
Targeted agents in older patients with gastrointestinal cancers - An overview.
Auteurs : Monteiro AR, Conde RS, Basto R, Sclafani F, Deleporte A, Hendlisz A, Dal Lago L Année : 2021 Journal : J Geriatr Oncol
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Auteurs : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart M Année : 2021 Journal : Breast Cancer Res Treat